Lincoln Pharmaceuticals makes additional investment in subsidiary

Acquires additional 36.58% stake in Lincoln Parenteral

Lincoln Pharmaceuticals announced that it has acquired 36.58% additional equity in its subsidiary, Lincoln Parenteral, taking the total investment up to 98.58%.

Powered by Capital Market - Live News